Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: | Brolene |
Active Ingredient: | Propamidine isetionate 0.1%w/v |
Dosage Form: | Eye drops, solution |
New Zealand Sponsor: | Sanofi-Aventis New Zealand Limited |
Manufacturer: | Zentiva ks, Prague, Czech Republic |
Product: | Canesten Clotrimazole Thrush 3 Day Cream |
Active Ingredient: | Clotrimazole 2%w/w |
Dosage Form: | Vaginal cream |
New Zealand Sponsor: | Bayer New Zealand Limited |
Manufacturers: | Kern Pharma SL, Barcelona, Spain Encube Ethicals Private Limited, Goa, India GP Grenzach Produktions GmbH, Grenzach-Wyhlen, Germany |
Product: | Lignocaine Gel (non-sterile) |
Active Ingredient: | Lidocaine hydrochloride monohydrate 2.2%w/w |
Dosage Form: | Topical gel |
New Zealand Sponsor: | Orion Laboratories (NZ) Limited |
Manufacturer: | Orion Laboratories Pty Limited t/a Perrigo Australia, Perth, Australia |
Product: | Livostin |
Active Ingredient: | Levocabastine hydrochloride 0.54mg/mL equivalent to levocabastine 0.50mg/mL |
Dosage Form: | Eye drops, suspension |
New Zealand Sponsor: | Johnson & Johnson (New Zealand) Limited |
Manufacturers: | Janssen Pharmaceutica NV, Plant 2, Beerse, Belgium Famar SA, Athens, Greece |
Dated this 17th day of July 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).